Supercharged immune cells take on childhood liver tumors
NCT ID NCT02932956
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 23 times
Summary
This early-stage trial tests a new treatment for children and young adults with a type of liver cancer that has returned or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in a lab to recognize and attack cancer cells that carry a protein called GPC3. The main goals are to find a safe dose and to see if these cells can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.